Opendata, web and dolomites

PD UpReg SIGNED

Gene knock-up via 3’UTR targeting to treat Parkinson’s disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PD UpReg project word cloud

Explore the words cloud of the PD UpReg project. It provides you a very rough idea of what is the project "PD UpReg" about.

gdnf    adult    hypothesize    humans    therapeutic    appropriate    model    mice    proteostasis    proof    function    gene    revolutionary    unlike    genes    ectopic    protect    death    protects    first    degeneration    spatiotemporal    levels    cas9    treating    therapy    met    mitochondrial    persons    pathogenesis    experiments    endogenous    life    physiologically    potent    shown    overexpressed    alpha    utr    least    toward    limited    elevated    neurotrophic    mouse    pattern    mediated    ntfs    causes    restricted    pd    treatment    safe    elderly    cells    crispr       dopaminergic    concurrently    collectively    restore    axons    incurable    ectopically    overexpressing    strategy    experimentally    parkinson    upregulating    synuclein    progress    made    suggesting    instead    deploy    defects    adulthood    provides    validation    create    disease    treat    transgenics    models    upregulate    thereby    neuronal    expression    editing    elevation    attempts   

Project "PD UpReg" data sheet

The following table provides information about the project.

Coordinator
HELSINGIN YLIOPISTO 

Organization address
address: YLIOPISTONKATU 3
city: HELSINGIN YLIOPISTO
postcode: 14
website: www.helsinki.fi

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 1˙999˙987 €
 EC max contribution 1˙999˙987 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-COG
 Funding Scheme ERC-COG
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) coordinator 1˙999˙987.00

Map

 Project objective

Parkinson’s disease (PD) affects 1% of elderly persons and is currently incurable. PD pathogenesis is driven, at least in part, by defects in proteostasis and mitochondrial function, leading to degeneration of dopaminergic axons and neuronal death. Neurotrophic factors (NTFs) such as GDNF can protect and restore dopaminergic axons. However, attempts to deploy NTFs ectopically in therapy models, or to increase proteostasis and mitochondrial function, have met with only limited success. I hypothesize that instead of ectopic application, over-expression of relevant pathways restricted to physiologically appropriate cells provides a potent therapeutic approach to treat PD. I have made significant progress toward this goal by targeting the 3’UTR in the mouse Gdnf gene, thereby increasing expression levels without affecting the gene’s spatiotemporal expression pattern. Using this approach I have shown that elevation of endogenous GDNF levels protects mice from experimentally induced PD. Unlike ectopic GDNF application, it causes no side effects. Importantly, I have established that GDNF levels can be elevated by 3’UTR targeting in adulthood, suggesting that this strategy could be applied in humans late in life. I will use 3’UTR targeting to study the therapeutic potential of overexpressing endogenous genes, using transgenics and CRISPR-Cas9‒mediated 3’UTR editing in adult mice. First, I will increase the expression of NTFs in adult mice with experimentally induced PD. Next, I will upregulate genes important in mitochondrial function and proteostasis and test whether concurrently upregulating endogenous NTFs is a viable approach for treating PD. Third, I will use 3’UTR targeting to create a mouse model of PD in which alpha-synuclein is overexpressed, for better validation of my therapeutic strategy. Collectively, these experiments should establish proof of concept for a revolutionary, safe and effective treatment for PD.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PD UPREG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PD UPREG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PGErepro (2019)

How to break Mendel’s laws? The role of sexual conflict in the evolution of unusual transmission genetics

Read More  

LO-KMOF (2019)

Vapour-deposited metal-organic frameworks as high-performance gap-filling dielectrics for nanoelectronics

Read More  

RESOURCE Q (2019)

Efficient Conversion of Quantum Information Resources

Read More